The Effects of the CF Carrier State on the Kidneys and Pancreas

Description

The overarching hypothesis is that CF carriers are at increased risk for developing most of the extrapulmonary conditions associated with CF compared to the general population. Specifically, it is hypothesized that this pilot data will detect subclinical evidence of pancreatic and kidney disorders among CF carriers. This will be determined by bringing CF carriers and controls to the CRU for one visit where they will answer survey questions and undergo laboratory testing. Additionally, they will collect urine and stool samples at home that will be sent to outside laboratories for testing.

Conditions

Carrier State, Pancreatic Disease, Kidney Diseases

Study Overview

Study Details

Study overview

The overarching hypothesis is that CF carriers are at increased risk for developing most of the extrapulmonary conditions associated with CF compared to the general population. Specifically, it is hypothesized that this pilot data will detect subclinical evidence of pancreatic and kidney disorders among CF carriers. This will be determined by bringing CF carriers and controls to the CRU for one visit where they will answer survey questions and undergo laboratory testing. Additionally, they will collect urine and stool samples at home that will be sent to outside laboratories for testing.

The Effects of the CF Carrier State on the Kidneys and Pancreas

The Effects of the CF Carrier State on the Kidneys and Pancreas

Condition
Carrier State
Intervention / Treatment

-

Contacts and Locations

Iowa City

University of Iowa Hospitals and Clinics, Iowa City, Iowa, United States, 52242

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * A CF Carrier identified via genetic testing
  • * CF patient status
  • * Unable to speak English
  • * Currently pregnant
  • * Unable to provide written informed consent
  • * Prisoner status
  • * Currently taking any medications for the treatment of diabetes

Ages Eligible for Study

18 Years to 100 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Philip Polgreen,

Philip M Polgreen, MD, PRINCIPAL_INVESTIGATOR, University of Iowa

Study Record Dates

2024-12